Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Income from Non-Controlling Interests (2018 - 2021)

Historic Income from Non-Controlling Interests for Amphastar Pharmaceuticals (AMPH) over the last 4 years, with Q3 2021 value amounting to -$1.4 million.

  • Amphastar Pharmaceuticals' Income from Non-Controlling Interests fell 26155.61% to -$1.4 million in Q3 2021 from the same period last year, while for Dec 2021 it was -$1.2 million, marking a year-over-year decrease of 13266.26%. This contributed to the annual value of $1.2 million for FY2021, which is 28725.49% up from last year.
  • Per Amphastar Pharmaceuticals' latest filing, its Income from Non-Controlling Interests stood at -$1.4 million for Q3 2021, which was down 26155.61% from -$855000.0 recorded in Q2 2021.
  • Over the past 5 years, Amphastar Pharmaceuticals' Income from Non-Controlling Interests peaked at $6.6 million during Q4 2019, and registered a low of -$3.0 million during Q1 2019.
  • In the last 4 years, Amphastar Pharmaceuticals' Income from Non-Controlling Interests had a median value of $326000.0 in 2019 and averaged $354384.6.
  • Its Income from Non-Controlling Interests has fluctuated over the past 5 years, first soared by 456241.61% in 2019, then crashed by 26155.61% in 2021.
  • Over the past 4 years, Amphastar Pharmaceuticals' Income from Non-Controlling Interests (Quarter) stood at -$149000.0 in 2018, then surged by 4562.42% to $6.6 million in 2019, then tumbled by 83.56% to $1.1 million in 2020, then plummeted by 229.19% to -$1.4 million in 2021.
  • Its Income from Non-Controlling Interests stands at -$1.4 million for Q3 2021, versus -$855000.0 for Q2 2021 and $1.1 million for Q1 2021.